Grant: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Primary Recipient
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Amount
$243,101.00
Award Date
9/01/2010
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Determination of serum prostate specific antigen (PSA) is an effective early screen for potential Prostate cancer with revenues estimated at over $350 million annually. Although the current screening method of PSA levels in the blood is valuable for early